Baclofen
ApprovedCompleted 0 views this week 0 watching💤 Quiet
Interest: 33/100
33
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Recurrent Crying Spells
Conditions
Recurrent Crying Spells
Trial Timeline
Dec 1, 2005 → Aug 1, 2013
NCT ID
NCT01955655About Baclofen
Baclofen is a approved stage product being developed by Brain Biotech for Recurrent Crying Spells. The current trial status is completed. This product is registered under clinical trial identifier NCT01955655. Target conditions include Recurrent Crying Spells.
What happened to similar drugs?
4 of 20 similar drugs in Recurrent Crying Spells were approved
Approved (4) Terminated (0) Active (16)
🔄Nivolumab + Gemcitabine + Cisplatin + Carboplatin + Paclitaxel + PemetrexedOno PharmaceuticalPhase 3
Hype Score Breakdown
Clinical
20
Activity
8
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01955655 | Approved | Completed |
Competing Products
20 competing products in Recurrent Crying Spells